← All verdicts
Verdict

Valuation N/A

Every analyzed stock in Valuation N/A479 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Valuation N/A" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

HVMCU
Highview Merger Corp.
Valuation N/A
Financial Services
Price$10.43
Model IV
P/IV
Limited data — see page
HVMCW
Highview Merger Corp.
Valuation N/A
Financial Services
Price$0.26
Model IV
P/IV
Limited data — see page
IACOU
Idea Acquisition Corp.
Valuation N/A
Financial Services Risk 44 · Elevated
Price$10.05
Model IV
P/IV
Limited data — see page
IACOW
Idea Acquisition Corp.
Valuation N/A
Financial Services Risk 46 · Elevated
Price$0.27
Model IV
P/IV
Limited data — see page
IACQU
Irenic Acquisition Corp.
Valuation N/A
Financial Services Risk 50 · Elevated
Price$10.04
Model IV
P/IV
Limited data — see page
IBAC
IB Acquisition Corp.
Valuation N/A
Industrials Risk 42 · Elevated
Price$10.92
Model IV
P/IV
Limited data — see page
IDACU
Iron Dome Acquisition I Corp.
Valuation N/A
Financial Services Risk 50 · Elevated
Price$10.10
Model IV
P/IV
Limited data — see page
IEAGU
Infinite Eagle Acquisition Corp.
Valuation N/A
Financial Services Risk 38 · Moderate
Price$10.37
Model IV
P/IV
Limited data — see page
ILLUU
Illumination Acquisition Corp. I
Valuation N/A
Financial Services Risk 45 · Elevated
Price$10.27
Model IV
P/IV
Limited data — see page
ILLUW
Illumination Acquisition Corp. I
Valuation N/A
Financial Services Risk 42 · Elevated
Price$0.37
Model IV
P/IV
Limited data — see page
IMSRW
Terrestrial Energy Inc. /DE/
Valuation N/A
Industrials Risk 62 · High
Price$1.71
Model IV
P/IV
Market implies +95.5%/yr
INACU
Indigo Acquisition Corp.
Valuation N/A
Financial Services Risk 49 · Elevated
Price$10.37
Model IV
P/IV
Limited data — see page
IPCXU
IPCXU
Valuation N/A
Price$5.80
Model IV
P/IV
Limited data — see page
IPEXU
Inflection Point Acquisition Corp. V
Valuation N/A
Financial Services Risk 33 · Moderate
Price$8.10
Model IV
P/IV
Limited data — see page
IPFXU
Inflection Point Acquisition Corp. VI
Valuation N/A
Financial Services Risk 64 · High
Price$10.45
Model IV
P/IV
Limited data — see page
IPFXW
Inflection Point Acquisition Corp. VI
Valuation N/A
Financial Services
Price$0.99
Model IV
P/IV
Limited data — see page
IPODU
IPODU
Valuation N/A
Price$10.74
Model IV
P/IV
Limited data — see page
IPODW
IPODW
Valuation N/A
Price$0.28
Model IV
P/IV
Limited data — see page
IQST
iQSTEL Inc
Valuation N/A
Communication Services Risk 31 · Moderate
Price$0.95
Model IV
P/IV
Market implies -50.0%/yr vs model +48.8% · below model
IRHOU
Iron Horse Acquisition II Corp.
Valuation N/A
Technology Risk 55 · Elevated
Price$10.16
Model IV
P/IV
Limited data — see page
ITHAU
ITHAX Acquisition Corp III
Valuation N/A
Financial Services Risk 40 · Elevated
Price$10.13
Model IV
P/IV
Limited data — see page
ITHAW
ITHAX Acquisition Corp III
Valuation N/A
Financial Services
Price$0.15
Model IV
P/IV
Limited data — see page
IVDAW
Iveda Solutions, Inc.
Valuation N/A
Technology Risk 46 · Elevated
Price$0.03
Model IV
P/IV
Market implies -50.0%/yr
JSPRW
Jasper Therapeutics, Inc.
Valuation N/A
Healthcare Risk 40 · Elevated
Price$0.01
Model IV
P/IV
Limited data — see page
JWEL
Jowell Global Ltd.
Valuation N/A
Consumer Cyclical Risk 43 · Elevated
Price$2.24
Model IV
P/IV
Market implies -50.0%/yr vs model +2.0% · below model
KBONU
Karbon Capital Partners Corp.
Valuation N/A
Financial Services Risk 49 · Elevated
Price$10.30
Model IV
P/IV
Limited data — see page
KBONW
Karbon Capital Partners Corp.
Valuation N/A
Financial Services Risk 37 · Moderate
Price$0.62
Model IV
P/IV
Limited data — see page
KCHVU
Kochav Defense Acquisition Corp.
Valuation N/A
Financial Services Risk 38 · Moderate
Price$10.52
Model IV
P/IV
Limited data — see page
KFIIU
K&F GROWTH ACQUISITION CORP. II
Valuation N/A
Financial Services Risk 38 · Moderate
Price$10.69
Model IV
P/IV
Limited data — see page
KIDZW
KIDZ AI Inc.
Valuation N/A
Consumer Defensive Risk 39 · Moderate
Price$0.01
Model IV
P/IV
Market implies -30.0%/yr
KLAC
KLA CORP
Valuation N/A
Technology Risk 55 · Elevated
Price$180.64
Model IV
P/IV
Market implies +36.6%/yr vs model +10.7% · above model
KOYNU
CSLM Digital Asset Acquisition Corp III, Ltd
Valuation N/A
Financial Services Risk 38 · Moderate
Price$10.31
Model IV
P/IV
Limited data — see page
KOYNW
CSLM Digital Asset Acquisition Corp III, Ltd
Valuation N/A
Financial Services
Price$0.22
Model IV
P/IV
Limited data — see page
KPLTW
KPLTW
Valuation N/A
Risk 47 · Elevated
Price$0.00
Model IV
P/IV
Limited data — see page
KRAQU
KRAKacquisition Corp
Valuation N/A
Financial Services Risk 40 · Elevated
Price$10.12
Model IV
P/IV
Limited data — see page
KRAQW
KRAKacquisition Corp
Valuation N/A
Financial Services Risk 31 · Moderate
Price$0.40
Model IV
P/IV
Limited data — see page
KTTAW
Pasithea Therapeutics Corp.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$0.00
Model IV
P/IV
Market implies -24.4%/yr
KTWOU
K2 Capital Acquisition Corp
Valuation N/A
Financial Services Risk 35 · Moderate
Price$10.26
Model IV
P/IV
Limited data — see page
KVACU
KVACU
Valuation N/A
Risk 38 · Moderate
Price$11.99
Model IV
P/IV
Limited data — see page
KVACW
KVACW
Valuation N/A
Risk 40 · Elevated
Price$0.02
Model IV
P/IV
Limited data — see page
KWMWW
Nexus Advanced Technologies Inc.
Valuation N/A
Communication Services Risk 47 · Elevated
Price$0.01
Model IV
P/IV
Limited data — see page
LAFAU
LaFayette Acquisition Corp.
Valuation N/A
Financial Services Risk 47 · Elevated
Price$10.22
Model IV
P/IV
Limited data — see page
LATAU
Galata Acquisition Corp. II
Valuation N/A
Financial Services Risk 36 · Moderate
Price$10.30
Model IV
P/IV
Limited data — see page
LATAW
Galata Acquisition Corp. II
Valuation N/A
Financial Services
Price$0.23
Model IV
P/IV
Limited data — see page
LCCCU
Lakeshore Acquisition III Corp.
Valuation N/A
Financial Services Risk 32 · Moderate
Price$10.61
Model IV
P/IV
Limited data — see page
LFACW
Leapfrog Acquisition Corp
Valuation N/A
Financial Services
Price$0.28
Model IV
P/IV
Limited data — see page
LIDRW
LIDRW
Valuation N/A
Risk 40 · Elevated
Price$0.00
Model IV
P/IV
Limited data — see page
LIMNW
Liminatus Pharma, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$0.04
Model IV
P/IV
Limited data — see page
LOKVU
LOKVU
Valuation N/A
Price$11.99
Model IV
P/IV
Limited data — see page
LOKVW
LOKVW
Valuation N/A
Price$1.86
Model IV
P/IV
Limited data — see page
LPAAU
Launch One Acquisition Corp.
Valuation N/A
Financial Services Risk 38 · Moderate
Price$11.11
Model IV
P/IV
Limited data — see page
LPAAW
Launch One Acquisition Corp.
Valuation N/A
Financial Services
Price$0.14
Model IV
P/IV
Limited data — see page
LPCVU
Launchpad Cadenza Acquisition Corp I
Valuation N/A
Financial Services Risk 36 · Moderate
Price$10.25
Model IV
P/IV
Limited data — see page
LPCVW
Launchpad Cadenza Acquisition Corp I
Valuation N/A
Financial Services
Price$0.32
Model IV
P/IV
Limited data — see page
LRCX
LAM RESEARCH CORP
Valuation N/A
Industrials Risk 43 · Elevated
Price$298.22
Model IV
P/IV
Market implies +27.3%/yr
LTM
LATAM AIRLINES GROUP S.A.
Valuation N/A
Industrials Risk 27 · Moderate
Price$51.29
Model IV
P/IV
Limited data — see page
LUCYW
Innovative Eyewear Inc
Valuation N/A
Healthcare Risk 27 · Moderate
Price$0.04
Model IV
P/IV
Market implies -50.0%/yr
LWACU
LightWave Acquisition Corp.
Valuation N/A
Financial Services Risk 38 · Moderate
Price$10.36
Model IV
P/IV
Limited data — see page
LWACW
LightWave Acquisition Corp.
Valuation N/A
Financial Services
Price$0.19
Model IV
P/IV
Limited data — see page
LYG
Lloyds Banking Group plc
Valuation N/A
Financial Services Risk 38 · Moderate
Price$6.01
Model IV
P/IV
Limited data — see page